Global Diabetes Situation: Over 1 in 10 Adults Affected, Prevention Is More Urgent Than EverDiabetes has long ceased being a disease confined to affluent nations—it has evolved in...

The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...

When people hear the word “generic drug,” they often think of cheap or low-quality medicine. In fact, this is a big misunderstanding. Generic drugs are not counterfeit medicines;...

When diagnosed with thrombocytopenia (low platelet count), many patients worry: “Does this mean I can’t live normally?” The answer is: you can, but your lifestyle will require s...

This page summarizes the latest approvals issued by the U.S. Food and Drug Administration (FDA). The list includes newly approved therapies as well as additional indications for ex...

September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...

When undergoing targeted cancer therapy, diet often becomes a concern for many patients. The truth is, there’s no need for overly strict restrictions, but maintaining a light, bal...

Natural killer (NK) cells play a central role within the innate immune system and are able to recognize abnormal cells without prior sensitization. In recent years, NK cell–based ...

On July 28, 2025 — World Hepatitis Day — Bangladesh-based Beacon Pharmaceuticals officially introduced Sofosvel, the world’s first generic version of Epclusa (SOF/VEL). This mil...

Cancer patients undergoing treatment require a carefully managed diet and healthy lifestyle to support recovery, improve treatment tolerance, and enhance quality of life. Here is a...